Previous close | 0.2982 |
Open | 0.2982 |
Bid | 0.3036 x N/A |
Ask | 0.3190 x N/A |
Day's range | 0.2982 - 0.2982 |
52-week range | 0.1830 - 0.3800 |
Volume | |
Avg. volume | 5,920 |
Market cap | 85.195M |
Beta (5Y monthly) | 1.38 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.2800 |
Earnings date | 08 Aug 2024 - 12 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 4.00 |
First Senhance® System placement at a dedicated pediatric hospital in the United StatesRESEARCH TRIANGLE PARK, N.C., July 24, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a global leader of innovative digital solutions for the operating room, announced that The Rocky Mountain Hospital for Children in Denver, Colorado, part of HCA Healthcare’s HealthONE network, has entered into an agreement to utilize a Senhance® Surgical System. “We are thrilled to announce the first d
RESEARCH TRIANGLE PARK, N.C., July 23, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a global leader of innovative digital solutions for the operating room, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) for an expanded indication to treat adult and pediatric Urology patients with the Senhance® Surgical System. “This FDA clearance marks another milestone for Asensus Surgical and represents an additional indication
Becomes the second hospital in Austria to utilize SenhanceRESEARCH TRIANGLE PARK, N.C., July 16, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient, announced that LKH-Universitätsklinikum Graz in Austria has entered into an agreement to lease and utilize a Senhance® Surgical System. LKH-Universitätsklinikum Graz is a renowned healthcare institution known for its expertise in minimally i